Accessibility Menu
Oncologix Tech logo

Oncologix Tech(OTC) OCLG

Market Cap$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-100%
5 Year-99%
1 Year+9,900%
1 Month+0%
$0.00
+0.00%
+0.00Today
Oncologix Tech last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-03
Oncologix Tech stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-21
1 month+0%USD 0.002026-06-23
3 month+9,900%USD 0.002026-02-19
Year to date+0%USD 0.002025-12-30
1 year+9,900%USD 0.002025-07-31
3 year-87.5%USD 0.002023-08-04
5 year-98.98%USD 0.012021-08-04
Since inception-100%USD 284.911992-05-01

Oncologix Tech Financials at a Glance

Market Cap

$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.16M

Net Income (TTM)

-$1.73M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

22.60 (High)

Price

$0.00

Volume

65,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jul 21, 2015

OCLG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oncologix Tech

Oncologix Tech Inc. is a diversified medical holding company that provides healthcare services across the United States. The company specializes in personal home care services and the manufacturing and distribution of medical technologies and products.

Products and Services
  • Personal home care services, including daily living assistance and Alzheimer's care
  • Manufacturing and distribution of medical technologies for various healthcare facilities
  • Sales of home medical equipment for sleep and respiratory therapies
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increasing demand for home healthcare services supports long-term growth potential
  • Strategic partnerships may enhance product offerings and market reach
Financial Highlights
  • Recent quarterly net income reported at -$18,774, indicating ongoing operational challenges
  • Trailing twelve months revenue of $0, reflecting a need for strategic financial management
  • Current market capitalization stands at $73,662, suggesting potential for growth
Oncologix Tech Inc. operates in a competitive healthcare landscape, focusing on both personal care services and medical technology. The company has faced financial challenges, as indicated by recent quarterly losses and a lack of revenue over the trailing twelve months. However, the growing demand for home healthcare services presents a significant opportunity for future growth. The company's strategic initiatives, including potential market expansion and partnerships, may enhance its position in the healthcare sector. Investors may find interest in the company's efforts to navigate its financial landscape while capitalizing on emerging market trends.
AI Generated • Jul 8, 2026

Industry

Healthcare Providers and Services

CEO

Frank Ikechukwu Igwealor, MBA, CPA

Headquarters

Lafayette, LA 70508, US

OCLG Financials

Key Financial Metrics (TTM)

Gross Margin

20.05%

Operating Margin

-30.35%

Net Income Margin

-83.19%

Return on Equity

94.77%

Return on Capital

-52.03%

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.66B

Volume

65.00K

Avg. Volume

70.59K

Financials (TTM)

Gross Profit

$578.41K

Operating Income

-$389.19K

EBITDA

-$644.92K

Operating Cash Flow

-$213.84K

Capital Expenditure

-$1.18K

Free Cash Flow

-$215.02K

Cash & ST Invst.

$4.85K

Total Debt

$23.62K

Oncologix Tech Performance Analysis

Oncologix Tech annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-08-31USD 0N/A
20222022-08-31USD 0N/A
Oncologix Tech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42017-08-31-16.7%
Q12017-11-30-11.9%
Q42022-08-31N/A
Q12022-11-30N/A
Oncologix Tech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-08-31USD 0.00N/A
20222022-08-31USD 0.00N/A
Oncologix Tech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42017-08-31-500.0%
Q12017-11-3083.3%
Q42022-08-31N/A
Q12022-11-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$166.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$870.16

N/A

Employees

191

N/A

Net Income

-$18.77K

+96.8%

EBITDA

-$18.77K

+95.2%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$4.85K

-83.2%

Total Debt

$23.62K

-99.2%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$23.62K

-94.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$18.77K

+90.5%

Operating Cash Flow

-$18.77K

+90.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AMLHAmerican Leisure Holdings, Inc.
$0.00+0.00%
IFANIFAN Financial, Inc.
$0.00+0.00%
TKCITurnKey Capital, Inc.
$0.06+0.00%
OHCSOptimus Healthcare Services, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About OCLG

What is the current price of Oncologix Tech?

Oncologix Tech is trading at $0.00 per share.

What is the 52-week range for Oncologix Tech?

Over the past 52 weeks, Oncologix Tech has traded between $0.00 and $0.00.

How much debt does Oncologix Tech have?

As of the most recent reporting period, Oncologix Tech reported total debt of $0.00.

How much cash does Oncologix Tech have on hand?

Oncologix Tech reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Oncologix Tech’s dividend yield?

Oncologix Tech does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.